Tscan Therapeutics Inc (TCRX)
N/A x N/A N/A x N/A
Post-market by (Cboe BZX)
1.6700 +0.0600 (+3.73%) 03/21/25 [NASDAQ]
N/A x N/A N/A x N/A
Post-market 1.6700 unch (unch) 16:10 ET
for Fri, Mar 21st, 2025
Try Excel 
Watch
-
Add or delete the symbol from one or more Watchlists.
-
Create New Watchlist
This name already in use.
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | 12-2023 | 12-2022 | 12-2021 | 12-2020 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 178,689 | 133,359 | 120,027 | 161,405 | 34,791 |
| Marketable Securities | 111,421 | 58,685 | N/A | N/A | N/A |
| TOTAL | $292,722 | $194,237 | $124,127 | $165,654 | $36,445 |
| Non-Current Assets | |||||
| PPE Net | 7,242 | 7,742 | 10,100 | 11,765 | 5,659 |
| Investments And Advances | 1,766 | 1,647 | 725 | 166 | 166 |
| Other Non-Current Assets | 69,388 | 68,523 | 64,139 | 10,522 | 7,468 |
| TOTAL | $78,396 | $77,912 | $74,964 | $22,453 | $13,293 |
| Total Assets | $371,118 | $272,149 | $199,091 | $188,107 | $49,738 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | N/A | 3,347 | N/A | N/A | N/A |
| Accounts payable and accrued liabilities | 4,278 | 2,374 | 2,912 | 1,765 | 2,910 |
| Accrued Expenses | 15,410 | 10,716 | 6,838 | 6,517 | 2,494 |
| TOTAL | $35,956 | $29,820 | $17,305 | $21,343 | $17,446 |
| Non-Current Liabilities | |||||
| Long Term Debt | 32,072 | 26,700 | 29,290 | N/A | N/A |
| Deferred Revenues | 11,698 | 10,137 | 3,874 | 11,410 | 10,627 |
| aiOther Non-Current Liabilities | 60,874 | 59,140 | 53,062 | 4,489 | 65,938 |
| TOTAL | $94,192 | $91,462 | $82,352 | $5,986 | $74,754 |
| Total Liabilities | $130,148 | $121,282 | $99,657 | $27,329 | $92,200 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 56,591 | 47,882 | 24,226 | 23,977 | N/A |
| Common Shares | 6 | 5 | 3 | 3 | 1 |
| Retained earnings | -375,096 | -247,597 | -158,379 | -92,158 | -43,533 |
| Other shareholders' equity | 51 | 0 | 0 | 0 | 0 |
| TOTAL | $240,970 | $150,867 | $99,434 | $160,778 | $-42,462 |
| Total Liabilities And Equity | $371,118 | $272,149 | $199,091 | $188,107 | $49,738 |